Today, Semler Scientific (Nasdaq: SMLR) shares rose over 2.64% to $35.37 after the company released its second quarter 2025 financial results, reporting an increase in net income driven by unrealized gains from its Bitcoin holdings.
Semler Scientific Reports Second Quarter 2025 Financial Results, BTC Holdings of 5,021 and BTC Yield of 31.3% YTD through July 31, 2025. $SMLR
— Joe Burnett, MSBA (@IIICapital) August 4, 2025
The company posted net income of $66.9 million, up from just $11,000 in the same period last year. The increase came despite a 43% drop in revenue, which fell to $8.2 million. Operating expenses climbed to $10.3 million, resulting in a $2.1 million operating loss for the quarter. However, the company’s $83.8 million unrealized gain on Bitcoin holdings pushed pre-tax income to $80.6 million.
“We have made excellent progress with our Bitcoin treasury strategy,” stated the executive chairman of Semler Scientific Eric Semler. “Year-to-date through July 31, 2025, this strategy has generated more than $110.4 million in unrealized gains and delivered a 31.3% BTC yield. We also deepened our connection to the Bitcoin community by appointing Natalie Brunell to our board of directors and hiring Joe Burnett as director of Bitcoin strategy.”
As of July 31, 2025, Semler reported holding 5,021 Bitcoins with a fair value of $586.2 million, up from 4,636 Bitcoins at the end of Q2. The company acquired approximately 1,829 Bitcoins during the quarter and July, spending a total of $195.4 million funded through operating cash flow, investment monetization, and proceeds from equity and debt offerings.
“During the quarter, we were very pleased to launch CardioVanta, a wholly owned subsidiary that will drive our future healthcare initiatives focused on early detection of heart failure and cardiac arrhythmia,” said the CEO of Semler Scientific Doug Murphy-Chutorian. “We believe CardioVanta positions us to deliver long-term value in our healthcare business as we continue to aggressively execute on our Bitcoin treasury strategy — establishing Semler Scientific as a dual-engine platform for growth.”
In addition to the new subsidiary, Semler Scientific entered a new at-the-market (ATM) equity offering agreement in April, allowing the company to issue and sell up to $500 million of its common stock. As of July 31, it had raised approximately $194.3 million under the new agreement.
“Semler Scientific entered into a new Controlled Equity Offering Sales Agreement with Barclays Capital Inc., Cantor Fitzgerald & Co., Canaccord Genuity LLC, Needham & Company, LLC, Craig-Hallum Capital Group LLC and Lake Street Capital Markets, LLC… in an ATM offering,” the press release stated.
Those interested can watch the full Semler Scientific Q2 2025 earnings call below for more information:
This post Semler Scientific Stock SMLR Rises After Bitcoin Gains Fuel Q2 Results first appeared on Bitcoin Magazine and is written by Oscar Zarraga Perez.
